ECG detects 44% CVDs
to be able to diagnose your heart disease.
But, did you know, ECG can only detect less than ½
of all common heart diseases?
As such, any opportunity for the early detection
of CVD is missed.
4 additional sensors.
Non-invasive, super quick,
diagnose up to 93% of all
common and significant CVDs
such as heart failure
and valve diseases at
the primary care level.
detected, the earlier preventative
and or pharmacological treatments
options can be accessed by patients.
at higher levels of care.
allowing you to see
your physician in remote area
in a regional, mobile clinic, etc.
waiting in line to see a cardiologist.
Only if the CHART report indicates
a problem with your heart,
a further examination by a cardiologist
“It is very trendy the problem of HF with diabetes.
In this case, if I do to one of my patients a test and
see that the left ventricular is a bit big,
I know it's the beginning
of HF so I can already start treatment.”
Post-Pandemic, CHART can assist physicians to deal with the anticipated 35% growth of COVID-19 associated heart disease.
Whether in patient presentation Primary Care settings, patients can be immediately screened for cardiac conditions, such as heart failure, that put them at higher risk of disability or even death.
CHART™ combines the best of ECHO, ECG, and Auscultation, which makes it the ideal screening device.
CHART allows immediacy of patient management decisions, on the spot, without the need for referral to Cardiology for Echocardiography confirmation.
For smaller and remote clinics, where staffing is minimal and Echocardiography services are not yet available, CHART's unique diagnostics capabilities help it fill a critical life-saving function.
2 different devices, doing 2 different tests, at 2 different levels of Care,
by 2 different healthcare professionals.